Diabetic ketoacidosis associated with risperidone treatment? [2]

Psychosomatics

Volumn 41, Issue 4, 2000, Pages 369-370

  Croarkin, Paul E ^a   Jacobs, Karl M ^a   Bain, Brian K ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

ADULT; CASE REPORT; DIABETIC KETOACIDOSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MALE; ORAL GLUCOSE TOLERANCE TEST; PSYCHOSIS;

EID: 0033947811     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.41.4.369     Document Type: Letter

References (5)

1. J.E. Leysen P.M. Janssen A.A. Megens Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity J Clin Psychiatry 55 1994 5 12
2. S.R. Marder R.C. Meibach Risperidone in the treatment of schizophrenia Am J Psychiatry 151 1994 825 835
3. D.G. Owens Extrapyramidal side effects and tolerability of risperidone: a review J Clin Psychiatry 55 1994 29 35
4. PDR, Psychotropic Prescribing Guide, 1999, pp 238–246.
5. L. Breum U. Bjerre J.F. Bak Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glycogen synthase and insulin receptor kinase activity Metabolism 40 1995 1570 1576